协调多层平台,为核酸治疗药物的开放创新提供支持
Yayoi Kawata1, Taisuke Ichimaru2, Masakazu Kogami2
1Department of Innovation Science, School of Environment and Society, Institute of Science Tokyo, Japan.
Drug discovery today
|January 10, 2025
概括
制药公司正在使用开放式创新来开发新的寡核酸治疗药物. 生物技术,制药和CDMO之间的战略联盟对于市场增长和可持续药物研发至关重要.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 药物发现和开发 药物发现和开发
背景情况:
- 由于不断发展的技术和各种医疗需求,制药行业面临着越来越大的创新压力.
- 寡核酸治疗药物代表了一种新的模式,需要新的研究和开发 (R&D) 方法.
研究的目的:
- 分析在寡核酸疗法研发中的组织间联盟.
- 探索建立新药模式新市场的要求.
- 了解生物制药行业开放创新的动态.
主要方法:
- 在R&D中分析组织间的联盟.
- 审查市场发展阶段的寡核酸治疗药物.
- 确定关键参与者及其在研发不同阶段的角色.
主要成果:
- 寡核酸治疗药物市场已经在不同的阶段发展.
- 在这些阶段,开放式创新策略的使用方式不同,适应技术进步.
- 成功建立市场需要建立平台:生物技术用于发现,制药用于监管事务,合同开发和制造组织 (CDMO) 用于制造.
结论:
- 组织间的合作对于推进新型药物模式,如寡核酸治疗方法至关重要.
- 战略联盟有助于在制药研发领域创造市场和创造可持续价值.
- 了解分阶段开发和平台要求是未来生物制药创新的关键.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Synthetic Biology
4.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
4.7K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
Ligand Binding and Linkage
3.0K
3.0K
Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K


